Drug Database
Back to search

Belgium· BE-AMP-SAM663178-00

Zegalogue 0.6 mg

A dasiglucagon product containing dasiglucagon hydrochloride, registered in Belgium by Zealand Pharma. The same ATC class is registered in 8 of our 19 countries.

ATC H04AA02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedZegalogue 0.6 mgATCH04AA02REGISTER NO.BE-AMP-SAM663178-00PACKS LISTED0CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about dasiglucagon hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Dasiglucagon is registered in 8 of 19 countries.

Countries holding a registration under ATC H04AA02 (dasiglucagon), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 4 of them publish a price we can compare per daily dose
Search dasiglucagon products by name

Dasiglucagon · ATC H04AA02

8 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Dasiglucagon Hydrochloride
Manufacturer
Zealand Pharma
Country
Belgium (BE)
ATC code
H04AA02
ATC class
Dasiglucagon
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Dasiglucagon in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dasiglucagon products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/55ba80aa-9662-4c07-8626-69392d418b5f
GET /v1/drugs/55ba80aa-9662-4c07-8626-69392d418b5f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection in pre-filled syringe",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Zegalogue 0.6 mg",
  "name_fr": "Zegalogue 0.6 mg",
  "name_nl": "Zegalogue 0.6 mg",
  "amp_code": "SAM663178-00",
  "strengths": [
    "0.6000",
    "0.6000",
    "0.6000",
    "0.6000"
  ],
  "pack_count": 2,
  "substances": [
    "Dasiglucagon Hydrochloride",
    "Dasiglucagon",
    "Sodium Chloride",
    "Sodium Hydroxide"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Dasiglucagon",
  "authorisation_numbers": [
    "EU/1/24/1829/004",
    "EU/1/24/1829/003"
  ]
}
API referenceMCP serverPlans

See everything about dasiglucagon.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console